| 1 | Melanoma, uveal | Enrichment | GNA11, GNAQ, PLCB4 | 6.36 |
| 2 | Ellis-van creveld syndrome | Enrichment | GLI1, PRKACA, PRKACB | 5.74 |
| 3 | Pigmented nodular adrenocortical disease, primary, 1 | Enrichment | GNAS, PRKAR1A | 5.09 |
| 4 | Ehlers-danlos syndrome, arthrochalasia type, 2 | Enrichment | COL1A1, COL1A2 | 5.09 |
| 5 | Pseudohypoparathyroidism | Enrichment | GNAS, PTH1R | 5.09 |
| 6 | Ehlers-danlos/osteogenesis imperfecta syndrome | Enrichment | COL1A1, COL1A2 | 5.09 |
| 7 | Phakomatosis cesioflammea | Enrichment | GNA11, GNAQ | 5.09 |
| 8 | Septopreoptic holoprosencephaly | Enrichment | GLI2, PTCH1, SHH | 5.01 |
| 9 | Midline interhemispheric variant of holoprosencephaly | Enrichment | GLI2, PTCH1, SHH | 5.01 |
| 10 | Microform holoprosencephaly | Enrichment | GLI2, PTCH1, SHH | 4.92 |
| 11 | Lobar holoprosencephaly | Enrichment | GLI2, PTCH1, SHH | 4.92 |
| 12 | Alobar holoprosencephaly | Enrichment | GLI2, PTCH1, SHH | 4.84 |
| 13 | Semilobar holoprosencephaly | Enrichment | GLI2, PTCH1, SHH | 4.76 |
| 14 | Brachydactyly, type e1 | Enrichment | PTH1R, PTHLH | 4.62 |
| 15 | High bone mass osteogenesis imperfecta | Enrichment | COL1A1, COL1A2 | 4.62 |
| 16 | Anastomosing haemangioma | Enrichment | GNA11, GNAQ | 4.62 |
| 17 | Ehlers-danlos syndrome, arthrochalasia type, 1 | Enrichment | COL1A1, COL1A2 | 4.32 |
| 18 | Polydactyly, preaxial ii | Enrichment | PTCH1, SHH | 4.32 |
| 19 | Osteogenesis imperfecta with normal sclerae, dominant form | Enrichment | COL1A1, COL1A2 | 4.32 |
| 20 | Capillary malformations, congenital | Enrichment | GNA11, GNAQ | 4.10 |
| 21 | Ehlers-danlos syndrome, classic type, 1 | Enrichment | COL1A1, COL1A2 | 3.92 |
| 22 | Osteogenesis imperfecta, type i | Enrichment | COL1A1, COL1A2 | 3.92 |
| 23 | Classic ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2 | 3.92 |
| 24 | Osteogenesis imperfecta, type ii | Enrichment | COL1A1, COL1A2 | 3.78 |
| 25 | Primary bone dysplasia | Enrichment | COL1A1, COL1A2 | 3.45 |
| 26 | Osteochondrodysplasia | Enrichment | COL1A1, COL1A2 | 3.36 |
| 27 | Osteogenesis imperfecta, type iv | Enrichment | COL1A1, COL1A2 | 3.21 |
| 28 | Osteoporosis | Enrichment | COL1A1, COL1A2 | 3.14 |
| 29 | Polydactyly, postaxial, type a1 | Enrichment | GLI1, PTCH1 | 3.08 |
| 30 | Osteogenesis imperfecta, type iii | Enrichment | COL1A1, COL1A2 | 3.08 |
| 31 | Ehlers-danlos syndrome | Enrichment | COL1A1, COL1A2 | 2.87 |
| 32 | Macs syndrome | Enrichment | PTCH1, SHH | 2.83 |
| 33 | Brittle bone disorder | Enrichment | COL1A1, COL1A2 | 2.71 |
| 34 | Holoprosencephaly 3 | Enrichment | SHH | 2.54 |
| 35 | Hypocalciuric hypercalcemia, familial, type ii | Enrichment | GNA11 | 2.54 |
| 36 | Acrodysostosis 1 with or without hormone resistance | Enrichment | PRKAR1A | 2.54 |
| 37 | Ehlers-danlos syndrome, cardiac valvular type | Enrichment | COL1A2 | 2.54 |
| 38 | Curry-jones syndrome | Enrichment | SMO | 2.54 |
| 39 | Pseudohypoparathyroidism, type ic | Enrichment | GNAS | 2.54 |
| 40 | Carney complex, type 1 | Enrichment | PRKAR1A | 2.54 |
| 41 | Schilbach-rott syndrome | Enrichment | PTCH1 | 2.54 |
| 42 | Osseous heteroplasia, progressive | Enrichment | GNAS | 2.54 |
| 43 | Microphthalmia/coloboma 5 | Enrichment | SHH | 2.54 |
| 44 | Polydactyly, preaxial i | Enrichment | GLI1 | 2.54 |
| 45 | Deafness, autosomal recessive 44 | Enrichment | ADCY1 | 2.54 |
| 46 | Culler-jones syndrome | Enrichment | GLI2 | 2.54 |
| 47 | Sturge-weber syndrome | Enrichment | GNAQ | 2.54 |
| 48 | Acth-independent macronodular adrenal hyperplasia 1 | Enrichment | GNAS | 2.54 |
| 49 | Spondylometaphyseal dysplasia with corneal dystrophy | Enrichment | PLCB3 | 2.54 |
| 50 | Polydactyly, postaxial, type a8 | Enrichment | GLI1 | 2.54 |
| 51 | Pituitary adenoma 3, multiple types | Enrichment | GNAS | 2.54 |
| 52 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 2 | Enrichment | COL1A2 | 2.54 |
| 53 | Auriculocondylar syndrome 2a | Enrichment | PLCB4 | 2.54 |
| 54 | Cardioacrofacial dysplasia 2 | Enrichment | PRKACB | 2.54 |
| 55 | Myxoma, intracardiac | Enrichment | PRKAR1A | 2.54 |
| 56 | Acrocapitofemoral dysplasia | Enrichment | IHH | 2.54 |
| 57 | Holoprosencephaly 9 | Enrichment | GLI2 | 2.54 |
| 58 | Hypocalcemia, autosomal dominant 2 | Enrichment | GNA11 | 2.54 |
| 59 | Pigmented nodular adrenocortical disease, primary, 4 | Enrichment | PRKACA | 2.54 |
| 60 | Brachydactyly, type e2 | Enrichment | PTHLH | 2.54 |
| 61 | Disorders of gnas inactivation | Enrichment | GNAS | 2.54 |
| 62 | Cardioacrofacial dysplasia 1 | Enrichment | PRKACA | 2.54 |
| 63 | Auriculocondylar syndrome 2b | Enrichment | PLCB4 | 2.54 |
| 64 | Asphyxia neonatorum | Enrichment | COL1A1 | 2.54 |
| 65 | Rickets | Enrichment | VDR | 2.54 |
| 66 | Prkar1b-related neurodegenerative dementia with intermediate filaments | Enrichment | PRKAR1B | 2.54 |
| 67 | Turner syndrome | Enrichment | PTCH1 | 2.54 |
| 68 | Monostotic fibrous dysplasia | Enrichment | GNAS | 2.54 |
| 69 | Monosomy 9q22.3 | Enrichment | PTCH1 | 2.54 |
| 70 | Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome | Enrichment | GLI2 | 2.54 |
| 71 | Phakomatosis cesiomarmorata | Enrichment | GNA11 | 2.54 |
| 72 | Mazabraud syndrome | Enrichment | GNAS | 2.54 |
| 73 | Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome | Enrichment | SHH | 2.54 |
| 74 | Hirschsprung disease 1 | Enrichment | IHH, SMO | 2.51 |
| 75 | Epiphyseal dysplasia, multiple, 1 | Enrichment | COL1A1 | 2.24 |
| 76 | Failure of tooth eruption, primary | Enrichment | PTH1R | 2.24 |
| 77 | Hypoparathyroidism, familial isolated, 1 | Enrichment | PTH | 2.24 |
| 78 | Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly | Enrichment | RUNX2 | 2.24 |
| 79 | Pseudohypoparathyroidism, type ia | Enrichment | GNAS | 2.24 |
| 80 | Metaphyseal chondrodysplasia, jansen type | Enrichment | PTH1R | 2.24 |
| 81 | Pallister-hall-like syndrome | Enrichment | SMO | 2.24 |
| 82 | Amelogenesis imperfecta, type ig | Enrichment | PRKAR1A | 2.24 |
| 83 | Bruck syndrome 1 | Enrichment | COL1A2 | 2.24 |
| 84 | Metaphyseal dysplasia, spahr type | Enrichment | MMP13 | 2.24 |
| 85 | Chondrodysplasia, blomstrand type | Enrichment | PTH1R | 2.24 |
| 86 | Cutis marmorata telangiectatica congenita | Enrichment | GNA11 | 2.24 |
| 87 | Spondyloepimetaphyseal dysplasia, missouri type | Enrichment | MMP13 | 2.24 |
| 88 | Dermatofibrosarcoma protuberans | Enrichment | COL1A1 | 2.24 |
| 89 | Eiken syndrome | Enrichment | PTH1R | 2.24 |
| 90 | Histiocytoma, angiomatoid fibrous | Enrichment | CREB1 | 2.24 |
| 91 | Pseudopseudohypoparathyroidism | Enrichment | GNAS | 2.24 |
| 92 | Solitary median maxillary central incisor | Enrichment | SHH | 2.24 |
| 93 | Bleeding disorder, platelet-type, 19 | Enrichment | PRKACG | 2.24 |
| 94 | White-sutton syndrome | Enrichment | GLI2 | 2.24 |
| 95 | Osteopetrosis, autosomal recessive 2 | Enrichment | TNFSF11 | 2.24 |
| 96 | Marbach-schaaf neurodevelopmental syndrome | Enrichment | PRKAR1B | 2.24 |
| 97 | Combined osteogenesis imperfecta and ehlers-danlos syndrome 1 | Enrichment | COL1A1 | 2.24 |
| 98 | Usher syndrome, type iv | Enrichment | PRKAR1A | 2.24 |
| 99 | Autosomal dominant hypocalcemia | Enrichment | GNA11 | 2.24 |
| 100 | Acrodysostosis | Enrichment | PRKAR1A | 2.24 |
| 101 | Stickler syndrome, type ii | Enrichment | COL1A1 | 2.24 |
| 102 | Fibrolamellar carcinoma | Enrichment | PRKACA | 2.24 |
| 103 | Ocular melanoma | Enrichment | PLCB4 | 2.24 |
| 104 | Ciliary dyskinesia, primary, 18 | Enrichment | PRKAR1B | 2.24 |
| 105 | Metaphyseal anadysplasia | Enrichment | MMP13 | 2.24 |
| 106 | Isolated primary pigmented nodular adrenocortical disease | Enrichment | PRKAR1A | 2.24 |
| 107 | Postaxial polydactyly type b | Enrichment | GLI1 | 2.24 |
| 108 | Acth-independent macronodular adrenal hyperplasia | Enrichment | GNAS | 2.24 |
| 109 | Dentinogenesis imperfecta | Enrichment | COL1A2 | 2.24 |
| 110 | Isolated radial hemimelia | Enrichment | SHH | 2.24 |
| 111 | Brachydactyly, type a1 | Enrichment | IHH | 2.07 |
| 112 | Cleidocranial dysplasia 1 | Enrichment | RUNX2 | 2.07 |
| 113 | Mccune-albright syndrome | Enrichment | GNAS | 2.07 |
| 114 | Syndactyly, type iv | Enrichment | SHH | 2.07 |
| 115 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi | Enrichment | GNA11 | 2.07 |
| 116 | Holoprosencephaly 7 | Enrichment | PTCH1 | 2.07 |
| 117 | Caffey disease | Enrichment | COL1A1 | 2.07 |
| 118 | Familial isolated hypoparathyroidism | Enrichment | PTH | 2.07 |
| 119 | Hypoplastic or aplastic tibia with polydactyly | Enrichment | SHH | 2.07 |
| 120 | Cleidocranial dysplasia | Enrichment | RUNX2 | 2.07 |
| 121 | Cushing syndrome due to bilateral macronodular adrenocortical disease | Enrichment | GNAS | 2.07 |
| 122 | Melanoma of soft tissue | Enrichment | CREB1 | 2.07 |
| 123 | Phenylketonuria | Enrichment | COL1A1 | 1.94 |
| 124 | Schizencephaly | Enrichment | SHH | 1.94 |
| 125 | Pseudohypoparathyroidism, type ib | Enrichment | GNAS | 1.94 |
| 126 | Auriculocondylar syndrome 1 | Enrichment | PLCB4 | 1.94 |
| 127 | Carney complex variant | Enrichment | PRKAR1A | 1.94 |
| 128 | Arrhythmogenic right ventricular dysplasia, familial, 10 | Enrichment | PRKAR1A | 1.94 |
| 129 | Developmental and epileptic encephalopathy 12 | Enrichment | PLCB1 | 1.94 |
| 130 | Congenital generalized lipodystrophy | Enrichment | FOS | 1.94 |
| 131 | Mantle cell lymphoma | Enrichment | CCND1 | 1.94 |
| 132 | Autosomal recessive osteopetrosis | Enrichment | TNFSF11 | 1.94 |
| 133 | Pediatric systemic lupus erythematosus | Enrichment | SPP1 | 1.94 |
| 134 | Primary hyperparathyroidism | Enrichment | PTH | 1.94 |
| 135 | Enchondromatosis, multiple, ollier type | Enrichment | PTH1R | 1.84 |
| 136 | Von hippel-lindau syndrome | Enrichment | CCND1 | 1.84 |
| 137 | Vitamin d-dependent rickets, type 2a | Enrichment | VDR | 1.84 |
| 138 | Histiocytoid hemangioma | Enrichment | FOS | 1.84 |
| 139 | Klippel-trenaunay-weber syndrome | Enrichment | GNAQ | 1.77 |
| 140 | Basal cell nevus syndrome 1 | Enrichment | PTCH1 | 1.77 |
| 141 | Basal cell carcinoma 1 | Enrichment | PTCH1 | 1.77 |
| 142 | Keratoconus | Enrichment | COL1A1 | 1.77 |
| 143 | Adrenocortical carcinoma | Enrichment | PRKAR1A | 1.77 |
| 144 | Brachydactyly | Enrichment | GNAS | 1.70 |
| 145 | Congenital hydrocephalus | Enrichment | PTCH1 | 1.70 |
| 146 | Overgrowth syndrome | Enrichment | PTCH1 | 1.70 |
| 147 | Spastic paraplegia 4, autosomal dominant | Enrichment | GNAS | 1.64 |
| 148 | Combined pituitary hormone deficiency | Enrichment | GLI2 | 1.64 |
| 149 | Developmental and epileptic encephalopathy 14 | Enrichment | PLCB1 | 1.59 |
| 150 | Primary hyperaldosteronism | Enrichment | GNAS | 1.59 |
| 151 | Leukemia, chronic lymphocytic | Enrichment | CCND1 | 1.55 |
| 152 | Septooptic dysplasia | Enrichment | SHH | 1.47 |
| 153 | Meningioma | Enrichment | SMO | 1.47 |
| 154 | Pulmonary disease, chronic obstructive | Enrichment | VDR | 1.43 |
| 155 | Acute promyelocytic leukemia | Enrichment | PRKAR1A | 1.43 |
| 156 | Medulloblastoma | Enrichment | PTCH1 | 1.40 |
| 157 | Rhabdomyosarcoma | Enrichment | PTCH1 | 1.35 |
| 158 | Inherited cancer-predisposing syndrome | Enrichment | PRKAR1A, PTCH1 | 1.26 |
| 159 | Craniosynostosis | Enrichment | GLI2 | 1.25 |
| 160 | Hepatocellular carcinoma | Enrichment | VDR | 1.21 |
| 161 | Microphthalmia | Enrichment | PTCH1 | 1.21 |
| 162 | Systemic lupus erythematosus | Enrichment | SPP1 | 0.97 |
| 163 | Benign epilepsy with centrotemporal spikes | Enrichment | PLCB1 | 0.95 |
| 164 | Centralopathic epilepsy | Enrichment | PLCB1 | 0.93 |
| 165 | Nephrotic syndrome | Enrichment | RUNX2 | 0.93 |
| 166 | West syndrome | Enrichment | PLCB1 | 0.92 |
| 167 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | COL1A1 | 0.92 |
| 168 | Body mass index quantitative trait locus 11 | Enrichment | GNAS | 0.87 |
| 169 | Hypertelorism | Enrichment | COL1A1 | 0.86 |
| 170 | Hereditary breast ovarian cancer syndrome | Enrichment | PTCH1 | 0.83 |
| 171 | Myeloma, multiple | Enrichment | CCND1 | 0.83 |
| 172 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | GLI2 | 0.83 |
| 173 | Autism | Enrichment | SHH | 0.73 |
| 174 | Primary ciliary dyskinesia | Enrichment | PRKAR1B | 0.71 |
| 175 | Colorectal cancer | Enrichment | CCND1 | 0.65 |
| 176 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | ADCY1 | 0.64 |
| 177 | Ovarian cancer | Enrichment | PTCH1 | 0.60 |